MedPath

Cohort study of osteoarthritis by MRI 3D analysis (Kanagawa Knee Study)

Not Applicable
Conditions
Adult
Registration Number
JPRN-UMIN000032826
Lead Sponsor
Tokyo Medical and Dental University
Brief Summary

MME was unchanged in KL grade 1 and KL grade 0, whereas it increased slightly in KL grade 2 and increased moderately in KL grade 3. Cartilage thickness first decreased in the medial tibial region in KL grade 2 subjects and in the medial femoral region in KL grade 3. Cartilage thinning occurred in the anterior central medial femoral subregion and in the anterior and middle external medial tibial subregions in KL grade 1, whereas it diffusely expanded in early and moderate knee OA.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
573
Inclusion Criteria

Not provided

Exclusion Criteria

1) People who cannot attend the second MRI examination one year later. 2) People who cannot obtain informed consent due to cognitive impairment. 3) People who cannot undergo MRI examination due to claustrophobia. 4) People who cannot undergo MRI examination due to metal in the body. 5) People with a history of surgery in either knee. 6) People who visited hospital for injury in either knee for more three months. 7) People who have osteoarthritis or history of fracture in either lower extremity. 8) People who are diagnosed as collagen disease such as rheumatoid arthritis. 9) People who have any knee injection or arthrocentesis. 10) People who are poor general condition. 11) People who are pregnant or possible pregnant. 12) People who have a consciousness of doing vigorous sports such as full marathon, triathlon, weight lifting. 13) People for whom involved doctors decide as not appropriate to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
3D MRI projected cartilage area ratio by generations and transition of projected cartilage area ratio for one year.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath